Certara (CERT) Expected to Announce Quarterly Earnings on Wednesday

Certara (NASDAQ:CERT) will likely be announcing its earnings results after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of $0.13 per share and revenue of $99.13 million for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

Certara Stock Performance

Shares of Certara stock opened at $14.03 on Wednesday. Certara has a one year low of $9.41 and a one year high of $19.87. The company has a market cap of $2.26 billion, a PE ratio of -70.15, a P/E/G ratio of 9.33 and a beta of 1.57. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.86 and a current ratio of 2.86. The business has a 50-day simple moving average of $12.20 and a 200-day simple moving average of $11.65.

Analysts Set New Price Targets

CERT has been the subject of a number of research analyst reports. Robert W. Baird lowered their price target on Certara from $18.00 to $13.00 and set a “neutral” rating for the company in a report on Tuesday, November 5th. Barclays lowered their price target on Certara from $14.00 to $12.00 and set an “equal weight” rating for the company in a report on Thursday, November 7th. Six equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Certara presently has a consensus rating of “Hold” and a consensus price target of $15.92.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.